A huge thank you to Drs. @JavleMilind, @docsudhakodali1, @kspencer725, Mark Ghobrial, and all of the distinguished speakers at today’s Houston Regional Symposium, hosted by CCF, @MethodistHosp, and @MDanderson. Connecting directly with patients and caregivers is at the heart of

🔥Just released😊 🍀🦀International collaboration of scientists, clinicians & patient advocates on CCA (@curecc @CharityAMMF @atuvibi 🙏 to all the participants for your effort & valuable contribution 👉Specialy to @PMRodrigues19 @chiarabraconi @CcaEns @PrecisionBTCnet

🙏🏼 for the opportunity to contribute to this effort @OHSUKnight @curecc #cholangiocarcinoma

💚 Fantastic effort establishing consensus and future efforts for #cholangiocarcinoma. DOWNSTAGING unresectable liver-only CCA with #Y90 TARE is officially a FIRST-LINE approach. 🧩 🔵TARE allows for: - ⬆️ Tumor response and control. - ⬆️ Future liver remnant growth. (🗝️

Cholangiocarcinoma 2026: Status Quo, Unmet Needs and Priorities - Juan Valle @staclinds @curecc https://t.co/oF3r2AsoTF #Cancer #Cholangiocarcinoma #GICancers #GIOnc #OncoDaily #Oncology #MedEd #MedTwitter #MedX #MedOnc @CancerWorldmag

🏅 Join Team CCF for the 2026 Bank of America Chicago Marathon! Team CCF has charity bibs available for the October 11, 2026 race. If you’d like to run with us in 2026, please email Meredith McGuffage (meredith.mcguffage@curecca.org) with your name, contact information, and

On September 29th, the third annual #ChelleStrong Golf Outing once again brought together friends, family, and community members to celebrate the life and legacy of Michelle “Chelle” Strati. This year’s outing drew more than 120 golfers to the course, joined by new sponsors,

🎉 Thank You to Our Amazing Team CCF Runners! Five incredible Team CCF members took on the Philadelphia Marathon, Half Marathon, and 8K—and together they raised $14,936 and counting to support cholangiocarcinoma research and patient programs! Congratulations to: Gretchen Pezza

💡 Insights from Clinical Cancer Researchers! Missed our live session on December 5? Watch now as Drs. @JavleMilind and Juan Valle share their personal experiences, challenges, and milestones in clinical cancer research. Learn about patient-centered science, career lessons,

https://t.co/nd9ExaThaO$ Wonderful to participate in this webinar. My journey as a clinical researcher. @curecc @Jarurat_care

🚨My take home message from #TOURMALINE at @myESMO #ESMOAsia25 👎Gem-alone underperforms vs doublet (agreed #DrChan) BUT… 🥳CisGemDurva in #PS2 from #Global population (n=18) SIMILAR to #TOPAZ (📸3-4) @GrupoTTD @atuvibi @CharityAMMF @curecc @enscca @myESMO #ESMOAsia25

Registration Is Open for the @curecc Annual Conference - @staclinds https://t.co/lVzqy1iC57 #Cancer #Medicine #Health #Oncology #OncoDaily #MedX #MedNews #MedEd

When Dr. Sheri Ford was diagnosed with cholangiocarcinoma in 2009, she faced it not only as a patient, but as a physician who understood the risks — and still moved forward with courage. Her journey included unexpected scans, surgeries, treatment, recurrence, and long seasons of

⏰ Happening tomorrow! Join us for the next ICRN/ENS-CCA Translational Science Seminar Series. 🧬 Translating HER2-Directed Therapy in Biliary Tract Cancer 📅 Dec 9 | 9 AM ET / 3 PM CET Featuring Prof. Joaquín Arribas (@joaquinarribas, @VHIO) and Dr. Funda Meric-Bernstam

📢 Houston Cholangiocarcinoma Symposium | Dec 12 Join leading experts for a day of learning & collaboration! 🌟 Highlights include: Kristen Spence: Novel Early-Phase Trial Design Dan Duda: Reprogramming the Microenvironment Maen Abdelrahim: Immunotherapy for iCCA Bruno

💚 It's okay if you don't feel merry and bright this holiday season. 💚 The holidays can be especially difficult for anyone who has lost a loved one. As the season of togetherness approaches, grief can feel heavier, and moments of joy can be tinged with sadness. At the

When Cindy Mrotek and Katie Glenn became caregivers for parents w/ #Cholangiocarcinoma, they found more than guidance: they found each other. Through the Cholangiocarcinoma Foundation, they navigated grief & built a lasting bond. @curecc Read more! https://t.co/IZQIB0eUPv

Looking forward to our GI Oncology Summit this Friday @HMethodistMD @MethodistHosp. Regional, National and International Esteemed faculty will be discussing 🔥 topics in GI malignancy. @ASCO @curecc @myESMO @VuMediHemOnc @DAVAOnc @OncLive

Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial - The Lancet Gastroenterology & Hepatology https://t.co/ft52tcp2Ak @curecc @enscca @MDAndersonNews

📢 2025 Houston Cholangiocarcinoma Symposium 📢 Join leading experts, researchers, healthcare professionals, patients, and advocates on December 12, 2025, in Houston for a full day of learning, collaboration, and sharing the latest in cholangiocarcinoma research and treatment.